On June 27, 2017, a member of the Massive Bio Team, Belisario A. Arango, M.D., took part of the Cancer Moonshot Project and the Biden Cancer Initiative Meeting in Washington, D.C. The meeting was hosted by Kim Thiboldeaux, CEO of Cancer Support Community and a member of the Board of Directors of the Biden Cancer Initiative. The purpose of this meeting was to update the cancer community on the accomplishments over the past year, since the announcement of the Moonshot challenge, and to discuss the goals that are expected to be reached over the next 4 years.
The market for oncology medication is booming, aiding the overall pharmaceutical industry growth. The oncology drug market is estimated to be almost USD 94 billion. Most of the top pharmaceutical players are either currently manufacturing oncology drugs or have oncology medications in their R&D pipelines.
DNA-based analysis of cytogenetic abnormalities identified correlations of clinical features in patients with uveal melanoma—namely, that larger ocular melanomas and older patient age are associated with increased risk for metastasis. Small-to-medium uveal melanomas are associated with lower metastatic risk.
With the arrival of two revolutionary treatment strategies, immunotherapy and personalized medicine, cancer researchers have found new hope — and a problem that is perhaps unprecedented in medical research.
Periodontal disease was associated with increased risk of several types of cancer in postmenopausal women, even in women who had never smoked, according to results of a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Your doctor says to you, "We discussed your case at our tumor board, and here is your treatment recommendation." So, what exactly is a tumor board and what role does it play in your cancer care?share on twitter This Q&A explains.
Researchers at UT Health San Antonio and two partner institutions are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive breast cancer in its tracks. The new agent is a molecule called ERX-11 that has blocked the growth of recurring breast cancer tumors.
Summer Sun Safety Month, observed in August, encourages you to enjoy your summer, but take precautions to avoid overexposure to the sun’s ultraviolet rays. And if you notice anything unusual on your skin, see your provider.